Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification

Celina Tretter; Niklas de Andrade Krätzig; Matteo Pecoraro; Sebastian Lange; Philipp Seifert; Clara von Frankenberg; Johannes Untch; Gabriela Zuleger; Mathias Wilhelm; Daniel P Zolg; Florian S Dreyer; Eva Bräunlein; Thomas Engleitner; Sebastian Uhrig; Melanie Boxberg; Katja Steiger; Julia Slotta-Huspenina; Sebastian Ochsenreither; Nikolas von Bubnoff; Sebastian Bauer; Melanie Boerries; Philipp J Jost; Kristina Schenck; Iska Dresing; Florian Bassermann; Helmut Friess; Daniel Reim; Konrad Grützmann; Katrin Pfütze; Barbara Klink; Evelin Schröck; Bernhard Haller; Bernhard Kuster; Matthias Mann; Wilko Weichert; Stefan Fröhling; Roland Rad; Michael Hiltensperger; Angela M Krackhardt

doi:10.1038/s41467-024-46724-8

. 2024 Mar 15;15:2364. doi: 10.1038/s41467-024-46724-8

Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification

Celina Tretter ^1,^2,^#, Niklas de Andrade Krätzig ^3,^4,^5,^#, Matteo Pecoraro ^6,⁷, Sebastian Lange ^3,^4,⁵, Philipp Seifert ², Clara von Frankenberg ², Johannes Untch ², Gabriela Zuleger ², Mathias Wilhelm ^8,⁹, Daniel P Zolg ⁸, Florian S Dreyer ², Eva Bräunlein ², Thomas Engleitner ^4,⁵, Sebastian Uhrig ^10,¹¹, Melanie Boxberg ^1,¹², Katja Steiger ^1,¹², Julia Slotta-Huspenina ¹², Sebastian Ochsenreither ^13,^14,¹⁵, Nikolas von Bubnoff ^16,^17,¹⁸, Sebastian Bauer ^19,²⁰, Melanie Boerries ^16,¹⁷, Philipp J Jost ^1,^2,^21,²², Kristina Schenck ^1,², Iska Dresing ^1,², Florian Bassermann ^1,^2,⁴, Helmut Friess ²³, Daniel Reim ²³, Konrad Grützmann ^24,^25,²⁶, Katrin Pfütze ¹⁰, Barbara Klink ^24,²⁷, Evelin Schröck ^24,^27,^28,^29,^30,^31,³², Bernhard Haller ³³, Bernhard Kuster ^1,^8,³⁴, Matthias Mann ⁶, Wilko Weichert ^1,¹², Stefan Fröhling ^10,³⁵, Roland Rad ^1,^3,^4,⁵, Michael Hiltensperger ^1,², Angela M Krackhardt ^1,^2,^4,^36,^✉

¹German Cancer Consortium (DKTK), partner site Munich and German Cancer Research Center (DKFZ), Heidelberg, Germany

²Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IIIrd Medical Department, Munich, Germany

³Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, IInd Medical Department, Munich, Germany

⁴Technical University of Munich, TUM School of Medicine, Center for Translational Cancer Research (TranslaTUM), Munich, Germany

⁵Technical University of Munich, TUM School of Medicine, Institute of Molecular Oncology and Functional Genomics, Munich, Germany

⁶Department of Proteomics and Signal Transduction, Max Plank Institute of Biochemistry, Munich, Germany

⁷Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland

⁸Technical University of Munich, TUM School of Life Sciences, Chair of Proteomics and Bioanalytics, Freising, Germany

⁹Technical University of Munich, TUM School of Life Sciences, Computational Mass Spectrometry, Freising, Germany

¹⁰German Cancer Consortium (DKTK), partner site Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany

¹¹Molecular Precision Oncology Program, NCT Heidelberg, Heidelberg, Germany

¹²Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, Institute of Pathology, Munich, Germany

¹³German Cancer Consortium (DKTK), partner site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany

¹⁴Charité Comprehensive Cancer Center, Charité – Universitätsmedizin Berlin, Berlin, Germany

¹⁵Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany

¹⁶German Cancer Consortium (DKTK), partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany

¹⁷Institute of Medical Bioinformatics and Systems Medicine (IBSM), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany

¹⁸Department of Hematology and Oncology, Medical Center, University of Schleswig Holstein, Campus Lübeck, Lübeck, Germany

¹⁹German Cancer Consortium (DKTK), partner site Essen and German Cancer Research Center (DKFZ), Heidelberg, Germany

²⁰Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Hospital Essen, Essen, Germany

²¹Clinical Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria

²²University Comprehensive Cancer Center Graz, Medical University of Graz, Graz, Austria

²³Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, Department of Surgery, Munich, Germany

²⁴German Cancer Consortium (DKTK), partner site Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany

²⁵Core Unit Molecular Tumor Diagnostics (CMTD), NCT Dresden, Dresden, Germany

²⁶Institute for Medical Informatics and Biometry, Faculty of Medicine, TU Dresden, Dresden, Germany

²⁷Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany

²⁸ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany

²⁹National Center for Tumor Diseases Dresden (NCT/UCC), Dresden, Germany

³⁰Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany

³¹Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany

³²Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany

³³Technical University of Munich, TUM School of Medicine, Klinikum rechts der Isar, Institute of AI and Informatics in Medicine, Munich, Germany

³⁴Technical University of Munich, TUM School of Life Sciences, Bavarian Biomolecular Mass Spectrometry Center (BayBioMS), Freising, Germany

³⁵Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany

³⁶Malteser Krankenhaus St. Franziskus-Hospital, Flensburg, Germany

^✉

Corresponding author.

^#

Contributed equally.

PMCID: PMC10943035 PMID: 38491045

Correction to: Nature Communications 10.1038/s41467-023-39570-7, published online 02 August 2023

With respect to the original “Data availability” statement, since the publication of this work, to ensure patient data privacy protection per request of the authors’ institute Technical University of Munich, the RNA-seq dataset from sorted CD8+ TILs originally deposited to the European Nucleotide Archive (ENA) with study accession number PRJEB61429 has been transferred to the European Genome-phenome Archive (EGA) under restricted access with the study identifier EGAS00001006706 (along with the other sequencing datasets generated in the study) and the dataset identifier EGAD50000000193. The “Data availability” section of the Article file (PDF and HTML versions) and the Data section of the Reporting Summary have been updated to reflect these changes.

PERMALINK

Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification

Celina Tretter

Niklas de Andrade Krätzig

Matteo Pecoraro

Sebastian Lange

Philipp Seifert

Clara von Frankenberg

Johannes Untch

Gabriela Zuleger

Mathias Wilhelm

Daniel P Zolg

Florian S Dreyer

Eva Bräunlein

Thomas Engleitner

Sebastian Uhrig

Melanie Boxberg

Katja Steiger

Julia Slotta-Huspenina

Sebastian Ochsenreither

Nikolas von Bubnoff

Sebastian Bauer

Melanie Boerries

Philipp J Jost

Kristina Schenck

Iska Dresing

Florian Bassermann

Helmut Friess

Daniel Reim

Konrad Grützmann

Katrin Pfütze

Barbara Klink

Evelin Schröck

Bernhard Haller

Bernhard Kuster

Matthias Mann

Wilko Weichert

Stefan Fröhling

Roland Rad

Michael Hiltensperger

Angela M Krackhardt

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases